| Hang Seng Index | 25.260 HKD | -0.400 | -1.559% | 710.52M | 18.00B | 23.260 (+8.599%) HKD as at 2025/02/25 | | |
| Hang Seng China Enterprises | 90.940 HKD | -1.540 | -1.665% | 151.03M | 13.78B | 86.975 (+4.559%) HKD as at 2025/02/25 | | |
| Hang Seng TECH Index | 5.355 HKD | -0.040 | -0.741% | 2.13B | 11.47B | 5.580 (-4.036%) HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.355 HKD | -0.085 | -1.562% | 198.27M | 1.07B | 6.590 (-18.741%) HKD as at 2025/02/25 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.608 HKD | +0.022 | +1.387% | 453.63M | 727.66M | 1.831 (-12.198%) HKD as at 2025/02/25 | | |
| Hang Seng China Enterprises | 10.530 HKD | -0.120 | -1.127% | 51.61M | 544.69M | 10.808 (-2.575%) HKD as at 2025/02/24 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.066 HKD | +0.058 | +2.888% | 191.81M | 394.37M | 2.726 (-24.209%) HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.580 HKD | -0.185 | -3.209% | 57.12M | 321.00M | 5.000 (+11.607%) HKD as at 2025/02/25 | | |
| Hang Seng TECH Index | 11.490 HKD | -0.110 | -0.948% | 25.05M | 288.35M | 12.133 (-5.297%) HKD as at 2025/02/24 | | |
| Hang Seng TECH Index | 5.440 HKD | -0.065 | -1.181% | 27.31M | 148.93M | 5.659 (-3.861%) HKD as at 2025/02/25 | | |
| FTSE China A50 | 14.700 HKD | -0.280 | -1.869% | 7.42M | 109.23M | 13.749 (+6.917%) HKD as at 2025/02/24 | | |
| CSI 300 | 45.980 HKD | -1.520 | -3.200% | 1.93M | 88.88M | 43.473 (+5.766%) HKD as at 2025/02/25 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 16.660 HKD | -0.200 | -1.186% | 5.18M | 87.09M | 10.297 (+61.792%) HKD as at 2025/02/25 | | |
| London Gold Fixing Price | 2,390.000 HKD | -17.000 | -0.706% | 26.46K | 63.04M | N/A | | |
| FTSE China A50 | 13.670 HKD | -0.250 | -1.796% | 3.72M | 51.00M | 12.681 (+7.797%) HKD as at 2025/02/25 | | |
| Hang Seng High Dividend Yield | 29.660 HKD | -0.520 | -1.723% | 1.50M | 44.80M | 24.714 (+20.012%) HKD as at 2025/02/24 | | |
| MSCI Asia APEX 50 | 64.620 HKD | -0.280 | -0.431% | 676.91K | 43.60M | 57.370 (+12.638%) HKD as at 2025/02/24 | | |
| NASDAQ-100 Index | 48.220 HKD | +0.560 | +1.175% | 673.31K | 32.54M | 43.161 (+11.723%) HKD as at 2025/02/24 | | |
| Hang Seng Index | 23.200 CNY | -0.280 | -1.193% | 1.18M | 27.30M | 21.745 (+6.692%) CNY as at 2025/02/25 | | |
| Hang Seng Index | 10.590 HKD | -0.080 | -0.750% | 2.51M | 26.59M | 10.736 (-1.358%) HKD as at 2025/02/24 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.712 HKD | -0.106 | -2.776% | 6.71M | 24.96M | 4.925 (-24.634%) HKD as at 2025/02/24 | | |
| FTSE China A50 | 12.530 CNY | -0.210 | -1.648% | 1.87M | 23.49M | 11.844 (+5.790%) CNY as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 16.500 HKD | -0.280 | -1.669% | 1.20M | 19.63M | 13.980 (+18.029%) HKD as at 2025/02/24 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 3.460 HKD | -0.070 | -1.983% | 4.76M | 16.32M | 3.260 (+6.151%) HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 3.880 HKD | -0.150 | -3.722% | 3.82M | 15.00M | 3.748 (+3.511%) HKD as at 2025/02/25 | | |
| CSI Hong Kong Dividend | 37.260 HKD | -0.520 | -1.376% | 342.20K | 12.75M | 32.341 (+15.209%) HKD as at 2025/02/25 | | |
| Hang Seng Index | 25.360 HKD | -0.380 | -1.476% | 472.00K | 12.01M | 23.346 (+8.629%) HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 4.360 HKD | -0.186 | -4.092% | 2.64M | 11.74M | 4.284 (+1.769%) HKD as at 2025/02/24 | | |
-1x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng China Enterprises | 24.320 HKD | -1.640 | -6.317% | 458.27K | 10.98M | N/A | | |
| MSCI China | 25.580 HKD | -0.380 | -1.464% | 371.80K | 9.50M | 23.954 (+6.787%) HKD as at 2025/02/24 | | |